NORML

MARCH 18, 2019

It expands the pool of patients eligible for cannabis therapy to include those diagnosed with post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy, among other newly specified conditions. Nonetheless, Gov.

Decriminalization 237

Decriminalization Chronic Pain Marijuana Legislation 237

The Cannigma

JUNE 30, 2021

To varying degrees, the three most common uses of medical marijuana in Massachusetts, Maine, and Maryland were to treat chronic pain, anxiety, and back and neck problems. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% Severe chronic pain 35,866 30.5% Cancer 5,717 4.9%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

The Blunt Truth

MARCH 12, 2020

The other increases research into the efficacy of marijuana in treating chronic pain and PTSD. Nevertheless, advocates are confident they will be able to get the initiative on the November 2020 ballot. In other federal action, the House Veterans Affairs Committee passed two bills related to medical marijuana.

Banking 105

Banking Chronic Pain Hemp Decriminalization 105

Leafwell

JANUARY 30, 2021

We sampled 15,000 Leafwell patients from 2020 and identified the top 5 qualifying conditions nationwide for getting a medical marijuana card. Anxiety Chronic pain Insomnia Post-traumatic stress disorder (PTSD) Depression It is important to note that some states do not include all of these conditions as qualifiers for getting a medical.

Conditions 111

Conditions Chronic Pain Patients Cannabis 111

The Cannigma

MAY 5, 2021

Scientists are still not sure, but one study carried out in Italy in 2020 found that out of 143 patients who had recovered from COVID-19, 87.4% Joint and muscle pain and a general soreness in many parts of the body is a common symptom reported by people with long COVID. How common is long COVID? Depression and anxiety.

Chronic Pain 145

Chronic Pain Research and Development Patients Treatment 145

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. Washington DC: Author.

Policy 81

Policy Research and Development Chronic Pain Cannabinoids 81

Healer

JANUARY 19, 2021

The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients. The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients. Peer Reviewed Medical Study .

Treatment 98

Treatment Data Chronic Pain Patients 98

Project CBD

SEPTEMBER 12, 2023

Though he has learned to live with his pain, at times its relentlessness makes him feel depressed, trapped in a lonely prison from which there’s no escape. At least that’s how it felt until one day in 2020, when Rosenfeld’s pain management specialist, Dr. Michele Weiner, mentioned a potential jailbreak: ketamine. J Clin Med.

Chronic Pain 236

Chronic Pain Treatment Cannabinoids Research and Development 236

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Leafwell

JULY 28, 2020

Leafwell and Vireo Health presented a webinar in July 2020 which. To do this, we partner with other industry experts in the cannabis space who share our passion and commitment to expanding the knowledge base around medical cannabis.

Chronic Pain 52

Chronic Pain Cannabis Nerve Pain Sleep 52

MedicalJane

JUNE 12, 2020

Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD. Study Findings. Fifty-eight percent of patients used CBD-dominant products.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Canna Care Docs

JUNE 5, 2025

While patient enrollment peaked in 2020, current levels remain significantly higher than when recreational cannabis became legal in 2018. These incentives make the program valuable, especially for patients managing chronic pain, cancer, PTSD, and other qualifying conditions. decrease from peak enrollment.

Patients 59

Patients Advocacy Marijuana Programs 59

LifeCannMD

MAY 27, 2025

Researchers followed chronic pain patients and found something fascinating: the group using just 2.5 to 5mg of THC got almost the same pain relief as people taking much higher doses we’re talking 64% pain reduction versus 71%. That’s roughly equivalent to a few grains of rice in terms of the actual medicine.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

United Patients Group

NOVEMBER 6, 2023

Some common conditions in seniors that may benefit from medical cannabis include: Chronic pain : Medical marijuana has shown promise in relieving chronic pain from conditions like arthritis, neuropathy, and musculoskeletal disorders. A review in 2020 found that CBD might improve sleep by reducing anxiety.

Chronic Pain 105

Chronic Pain Strains Sleep THC 105

NORML

MARCH 7, 2020

House Bill 330 adds chronic pain associated with fibromyalgia to the set of conditions qualifying a patient for treatment with medical marijuana. Update : SB 420 is scheduled for a Health, Human Services and Elderly Affairs Work Session at 11am on 3/18/2020 in Legislative Office Building 104. NH resident?

Legislation 255

Legislation Decriminalization Patients THC 255

Cannabis Law Report

JUNE 15, 2021

And on many fronts, that push is being led by former athletes, well aware of the benefits that cannabis is offering them in their constant battle for relief from the chronic pain that comes from years of playing a violent, contact sport. To date, 16 states plus Washington, D.C. have fully legalized cannabis.

Chronic Pain 97

Chronic Pain Marijuana Sleep THC 97

Veriheal

AUGUST 16, 2021

In March of 2020, NFL team owners removed the possibility of players being suspended over positive drug tests. The issue is considered to be a Public Health Crisis, and new options and alternatives for pain management and the treatment of chronic pain need to be explored. This covered all drugs, not just cannabis.

Therapy 105

Therapy Chronic Pain Research and Development Treatment 105

Veriheal

APRIL 11, 2024

million registered in 2020 and an even more dramatic rise from the 678,000 registered in 2016. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic. million patients in 2022, a sharp increase from the 3.1

Patients 111

Patients Chronic Pain Marijuana Conditions 111

The Blunt Truth

OCTOBER 22, 2021

The Veterans Administration continues to oppose research into medical marijuana’s possible use in treating PTSD and chronic pain. Regular readers will doubtless recall that South Dakota and Mississippi both had legalization measures on their 2020 ballots (South Dakota both medical and adult-use; Mississippi medical only).

DEA 111

DEA Chronic Pain Legalization Marijuana 111

Canna Law Blog

FEBRUARY 19, 2020

Psilocybin will continue to be decriminalized around the United States in 2020 and beyond. This targeted pharmaceutical approach will serve psilocybin promoters well, as contrasted with cannabis, which has been touted broadly and amorphously for every use from chronic pain to Alzheimer’s disease.

Decriminalization 133

Decriminalization Research and Development Therapy Pharmaceutical 133

Cannabis Law Report

JUNE 24, 2021

Secondly, a tender to find a new supplier at the end of 2020 resulted in none of the bids being accepted. Of the numerous delayed orders, the longest was 60 days in 2020, for a THC product. Firstly, there was a peak in consumption up to April 2021. One supplier announced a new offer, which “is currently being evaluated.”

Medicine 80

Medicine Chronic Pain Treatment Patients 80

Otherside Farms

MAY 21, 2020

2020 has been a unique year in terms of commerce and industry. So, what are the market trends in CBD products for 2020, and what can we expect for the future? Many thousands of people use CBD products to self-medicate, citing its usefulness in helping with chronic pain as a major selling point. Further Medical Use.

CBD 52

CBD Vaping Supply Chain Research and Development 52

The Cannigma

JUNE 25, 2022

A 2020 Kantar poll found that 55% of respondents don’t believe a small amount of cannabis should be worthy of jail time but only 21% believed cannabis should be fully legal. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy.

Legalization 119

Legalization Supply Chain Chronic Pain Tincture 119

NORML

FEBRUARY 8, 2019

Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. At a more local level, efforts are underway in Ann Arbor, Michigan to put a cannabis social use question before voters on the 2020 ballot. CT resident?

Legislation 197

Legislation Decriminalization Patients Access 197

The Blunt Truth

OCTOBER 10, 2019

In South Dakota , where Governor Noem vetoed an industrial hemp legalization bill earlier this year, legislators are working on new legislation to be introduced in 2020. And researchers at the University of Georgia will be studying medical cannabis as a treatment for chronic pain.

Chronic Pain 77

Chronic Pain Banking Hemp Legislation 77

Project CBD

SEPTEMBER 12, 2023

Though he has learned to live with his pain, at times its relentlessness makes him feel depressed, trapped in a lonely prison from which there’s no escape. At least that’s how it felt until one day in 2020, when Rosenfeld’s pain management specialist, Dr. Michele Weiner, mentioned a potential jailbreak: ketamine. J Clin Med.

Chronic Pain 130

Chronic Pain Treatment Cannabinoids Research and Development 130

The Cannigma

OCTOBER 8, 2022

The law named three conditions as qualifiers for medical weed: chronic pain, spasticity in multiple sclerosis, and side effects of chemotherapy. Prescriptions can only be given by doctors and dispensed by a pharmacist. Patients can access the raw plant, but smokable versions are not included.

Law 105

Law Chronic Pain Access Recreational 105

CannaMD

SEPTEMBER 9, 2020

Published only recently, in May of 2020, this clinical trial is the first to show that microdoses of cannabis can be just as effective as much higher doses. They gave 27 patients with chronic pain (reporting pain levels of at least six out of 10) one of the following treatment options: 5mg of inhaled THC.

Microdosing 111

Microdosing Marijuana Clinical Trials Chronic Pain 111

Veriheal

JULY 21, 2022

On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020. Chronic pain. Amyotrophic Lateral Sclerosis (ALS) . Cachexia and wasting syndrome. Crohn’s disease. Fibromyalgia.

Access 105

Access Dispensary Patients Programs 105

Puff Puff Post

NOVEMBER 5, 2019

Research will be funded via the country’s 2020 social security budget. “I sincerely hope that the experiments can begin in the first quarter of 2020,” junior health minister Christelle Dubos said after the vote. . The post France Approves Medical Cannabis Research for 2020 appeared first on Puff Puff Post.

Chronic Pain 40

Chronic Pain Patients Epilepsy Environment 40

Cannabis Law Report

SEPTEMBER 9, 2021

Based on the sources, the marijuana segment accounted for the highest revenue share in 2020 and is expected to exhibit the fastest growth rate during the forecast period. The medical end-use segment dominated the market in 2020 and will retain the leading position during the forecast years. Chronic Pain. Chronic Pain.

Recreational 73

Recreational Hemp THC Legalization 73

Veriheal

APRIL 26, 2022

In 2020, legal cannabis constituted a $12.8 Application: Adult-Use, B2B Avenues, and Medical were studied in-depth for the report, with the latter category being further segmented into Anxiety, Chronic Pain, Inflammation, and Sleep Disorders. billion by 2026. billion global industry.

Supply Chain 98

Supply Chain Legalization Research and Development Chronic Pain 98

Veriheal

AUGUST 7, 2022

As of 2020, the market was worth CAD $2.6 Examples include chronic pain, chemotherapy-related nausea and vomiting, anxiety, depression, and muscle inflammation. All of the study subjects were enrolled in the nation’s federally legal medical cannabis program, which was launched by Health Canada back in 2001.

Consumption 111

Consumption Patients Research and Development Data 111

Marijuana Seeds NL

MAY 27, 2020

Originally posted 8th June 2017, Updated on 27th May 2020. Chronic pain. Neuropathic pain. A 2012 study shows advanced cancer patients given THC/CBD compounds at low, medium and high doses showed the highest decrease in pain from low doses. Microdosing may be a term you’re already aware of. Depression.

Microdosing 98

Microdosing Chronic Pain Edibles Vaping 98

TheAnswerPage

JULY 9, 2022

Chronic pain was the most common qualifying condition for receiving medical cannabis in 2020 in the US. What percentage of patients reported chronic pain as their qualifying condition? What was the second most common qualifying condition in 2020? of patients listed that as their qualifying condition.

Chronic Pain 40

Chronic Pain Conditions Patients Programs 40

The Fresh Toast

JUNE 14, 2022

Medical cannabis program enrollment jumped by over four times between 2016 and 2020, reaching nearly three million patients in 2020. Medical Marijuana Enrollment Is At All Time High — Here’s The Reason. The post Medical Marijuana Enrollment Is At All Time High — Here’s The Reason appeared first on The Fresh Toast.

Marijuana 98

Marijuana Programs Patients Chronic Pain 98

Canna Law Blog

JUNE 29, 2019

Every Saturday, at least for a while, we plan to run a series of blog posts that take a close look at each of the Democratic Party candidates for President in 2020. ” Biden gets one thing right: we do need more research surrounding pain management. Today, we start with Joe Biden, the former vice president and U.S.

Marijuana 105

Marijuana Policy Chronic Pain Treatment 105